Keywords
Last Name
Institution

Pass Through Agency: Mary Crowley Medical Research Center
Funding Agency: Gradalis, Inc.
Title: Randomized Phase IIb Trial of Vigil versus gemcitabine + docetaxel for Ewing's Sarcoma
Start Date: 2016-11-02


Collapse Overview 
Collapse researcher role of